The Netherlands Centre for One Health (NCOH) was allocated a budget of two million euro Public-Private Partnership (PPP) Allowance to organise and realise their first PPP call. This call involves strategic partnerships under the Knowledge and Innovation Agenda of Top Sector Life Sciences & Health (LSH): One Health call.
The research projects should fit within the NCOH Strategic Research Agenda and one of its Solution Sets ‘Preventive Strategies’ or ‘Prophylactic Vaccines’. All NCOH partners can apply for collaborative innovation projects; though specific NCOH consortium criteria must be met.
Depending on the type of research (fundamental, industrial or experimental) and the contributions by private and public partners within the project, between €250,000 and €750,000 PPP Allowance can be applied for. Submitted projects should have a total size of max. €1 million, including co-financing. An important condition is that an application must consist of a collaboration with at least one private party and an NCOH consortium of at least two contributing NCOH partners with multiple PhD students, befitting the NCOH research programme.
Please download the “One Health call” description here and read more about the call and the requirements for applications. The call application form and annexes are the same as for the PPP Allowance Match Call. The NCOH advises applicants to use the services of their own Partner Organisations (e.g. experts from research support office, technology transfer office (TTO) or a lawyer) for details on the call and writing of the proposal. Additional NCOH information can be requested through Vincent Rijsman, of the Veterinary Faculty Utrecht University, who functioned as the liason between NCOH and Top Sector LSH.
Applications can be submitted until 9 October 2019 (12.00 CE(S)T) to Jovanka Bestebroer by the main applicant.
The number of bacteria that are resistant to antibiotics is increasing globally. In the Netherlands this number remains fairly stable and is lower than in many other countries. Nevertheless, there is still cause for concern and caution. This is evident from the annual report NethMap/MARAN 2019 in which various organisations jointly present data on antibiotic...
A malaria vaccine, based on genetically-manipulated malaria parasites. That is the goal of Meta Roestenberg (LUMC) and Robert Sauerwein (Radboudumc). More than ten years of collaboration is nearing completion. But the vaccine could be even better…
The second edition of the NCOH Magazine has been published at the Annual Scientific Meeting at Radboudumc 17 may. Here is your chance to look at the digital version.
Will we be able to respond adequately when an unknown virus with pandemic potential emerges? The recent outbreak of MERS in the Middle East was an interesting testcase. Martine van Roode (Erasmus MC) and Carolina dos Santos Ribeiro (RIVM) analysed the factors that hampered, or enabled, the flow of information, in Qatar and the wider...